India's product patent regime for drugs, which is now five years old, is set to enter a phase in which there will be a distinct change in the kind of patents sought as well as patent challenges,......
MSD India, a wholly owned subsidiary of American drug maker Merck & Co, plans to hire 300 people this year as it looks to expand its presence in the Indian market, where it intends to introduce......
When United States-based drug major Merck bought Schering-Plough early this month, it decided to go off the beaten track. Instead of having one managing director for the merged entity, it decided......